Catecholamines induce an inflammatory response in human hepatocytes

Critical Care Medicine

Volumn 36, Issue 3, 2008, Pages 848-854

  Aninat, Caroline ^a   Seguin, Philippe ^a   Descheemaeker, Pierre Néri ^a   Morel, Fabrice ^a   Malledant, Yannick ^a   Guillouzo, André ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Catecholamines; Cytochrome P450; HepaRG cells; Human hepatocytes; Inflammation; Septic shock; Vasopressin

Indexed keywords

ADRENALIN; C REACTIVE PROTEIN; CATECHOLAMINE; CLONIDINE; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450 1A2; CYTOCHROME P450 2B6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; DOBUTAMINE; DOPEXAMINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NORADRENALIN; PHENYLEPHRINE; PREGNANE X RECEPTOR; RNA; SALBUTAMOL; VASOPRESSIN;

ADULT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG METABOLISM; ENZYME ACTIVITY; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INFLAMMATION; LIVER CELL; LIVER FUNCTION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SEPSIS; SEPTIC SHOCK; CELL CULTURE; IMMUNOLOGY;

CATECHOLAMINES; CELLS, CULTURED; HEPATOCYTES; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; SEPSIS;

EID: 44149089220     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0B013E31816532BE     Document Type: Article

References (60)

1. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554
2. Shapiro N, Howell MD, Bates DW, et al: The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med 2006;48:583-590, e581
3. Knaus WA, Draper EA, Wagner DP, et al: Prognosis in acute organ-system failure. Ann Surg 1985;202:685-693
4. Dhainaut JF, Marin N, Mignon A, et al: Hepatic response to sepsis: Interaction between coagulation and inflammatory processes. Crit Care Med 2001;29(7 Suppl):S42-S47
5. Koo DJ, Chaudry IH, Wang P: Kupffer cells are responsible for producing inflammatory cytokines and hepatocellular dysfunction during early sepsis. J Surg Res 1999;83:151-157
6. Nanbo A, Nishimura H, Muta T, et al: Lipopolysaccharide stimulates HepG2 human hepatoma cells in the presence of lipopolysaccharide-binding protein via CD14. Eur J Biochem 1999;260:183-191
7. Liu S, Gallo DJ, Green AM, et al: Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun 2002;70:3433-3442
8. Migita K, Abiru S, Nakamura M, et al: Lipopolysaccharide signaling induces serum amyloid A (SAA) synthesis in human hepatocytes in vitro. FEBS Lett 2004;569:235-239
9. Wang P, Tait SM, Chaudry IH: Sustained elevation of norepinephrine depresses hepatocellular function. Biochim Biophys Acta 2000;1535:36-44
10. Siarakas S, Damas E, Murrell WG: The effect of enteric bacterial toxins on the catecholamine levels of the rabbit. Pathology 1997;29:278-285
11. Yang S, Koo DJ, Zhou M, et al: Gut-derived norepinephrine plays a critical role in producing hepatocellular dysfunction during early sepsis. Am J Physiol Gastrointest Liver Physiol 2000;279: G1274-G1281
12. Yang S, Zhou M, Chaudry IH, et al: Norepinephrine-induced hepatocellular dysfunction in early sepsis is mediated by activation of alpha2-adrenoceptors. Am J Physiol Gastrointest Liver Physiol 2001;281: G1014-G1021
13. Zhou M, Das P, Simms HH, et al: Gut-derived norepinephrine plays an important role in up-regulating IL-1beta and IL-10. Biochim Biophys Acta 2005;1740:446-452
14. Hollenberg SM, Ahrens TS, Annane D, et al: Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004;32:1928-1948
15. Levy B, Nace L, Bollaert PE, et al: Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrinetreated septic shock. Intensive Care Med 1999;25:942-948
16. Seguin P, Bellissant E, Le Tulzo Y, et al: Effects of epinephrine compared with the combination of dobutamine and norepineph-rine on gastric perfusion in septic shock. Clin Pharmacol Ther 2002;71:381-388
17. De Backer D, Creteur J, Silva E, et al: Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: Which is best? Crit Care Med 2003;31:1659-1667
18. Seguin P, Laviolle B, Guinet P, et al: Dopexamine and norepinephrine versus epinephrine on gastric perfusion in patients with septic shock: A randomized study [NCT00134212]. Crit Care 2006;10: R32
19. Shimamoto Y, Kitamura H, Iwai M, et al: Mechanism of decrease in levels of hepatic P450 isozymes induced by intracerebral endotoxin: Independence from sympathetic nervous and adrenocortical systems. Arch Toxicol 1999;73:41-49
20. Sidhu JS, Omiecinski CJ: cAMP-associated inhibition of phenobarbital-inducible cytochrome P450 gene expression in primary rat hepatocyte cultures. J Biol Chem 1995;270:12762-12773
21. Iber H, Li-Masters T, Chen Q, et al: Regulation of hepatic cytochrome P450 2C11 via cAMP: Implications for down-regulation in diabetes, fasting, and inflammation. J Pharmacol Exp Ther 2001;297:174-180
22. Viitala P, Posti K, Lindfors A, et al: cAMP mediated upregulation of CYP2A5 in mouse hepatocytes. Biochem Biophys Res Commun 2001;280:761-767
23. Gripon P, Rumin S, Urban S, et al: Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci USA 2002;99:15655-15660
24. Aninat C, Piton A, Glaise D, et al: Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab Dispos 2006;34:75-83
25. Guguen-Guillouzo C, Campion JP, Brissot P, et al: High yield preparation of isolated human adult hepatocytes by enzymatic perfusion of the liver. Cell Biol Int Rep 1982;6:625-628
26. Le Corre P, Malledant Y, Tanguy M, et al: Steady-state pharmacokinetics of dopamine in adult patients. Crit Care Med 1993;21:1652-1657
27. Delmas A, Leone M, Rousseau S, et al: Clinical review: Vasopressin and terlipressin in septic shock patients. Crit Care 2005;9:212-222
28. Beloeil H, Mazoit JX, Benhamou D, et al: Norepinephrine kinetics and dynamics in septic shock and trauma patients. Br J Anaesth 2005;95:782-788
29. Collins JL, Vodovotz Y, Yoneyama T, et al: Catecholamines decrease nitric oxide production by cytokine-stimulated hepatocytes. Surgery 2001;130:256-264
30. Burysek L, Houstek J: Beta-adrenergic stimulation of interleukin-1 alpha and interleukin-6 expression in mouse brown adipocytes. FEBS Lett 1997;411:83-86
31. Rensing H, Bauer I, Kubulus D, et al: Heme oxygenase-1 gene expression in pericentral hepatocytes through beta 1-adrenoceptor stimulation. Shock 2004;21:376-387
32. Jover R, Bort R, Gomez-Lechon MJ, et al: Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: Molecular mechanism and transcription factors involved. FASEB J 2002;16:1799-1801
33. Marnell L, Mold C, Du Clos TW: C-reactive protein: Ligands, receptors and role in inflammation. Clin Immunol 2005;117:104-111
34. Frost RA, Nystrom GJ, Lang CH: Epinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: Role of c-Jun. NH2-terminal kinase and histone deacetylase activity. Am J Physiol Endocrinol Metab 2004;286: E809-E817
35. Gornikiewicz A, Sautner T, Brostjan C, et al: Catecholamines up-regulate lipopolysaccharide-induced IL-6 production in human microvascular endothelial cells. Faseb J 2000;14:1093-1100
36. Jung BD, Kimura K, Kitamura H, et al: Norepinephrine stimulates interleukin-6 mRNA expression in primary cultured rat hepatocytes. J Biochem (Tokyo) 2000;127:205-209
37. Hahn PY, Wang P, Tait SM, et al: Sustained elevation in circulating catecholamine levels during polymicrobial sepsis. Shock 1995;4:269-273
38. Jellema WT, Groeneveld AB, Wesseling KH, et al: Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock. Crit Care Med 2006;34:2392-2398
39. Guirao X, Kumar A, Katz J, et al: Catecholamines increase monocyte TNF receptors and inhibit TNF through beta 2-adrenoreceptor activation. Am J Physiol 1997;273: E1203-1208
40. Tan KS, Nackley AG, Satterfield K, et al: Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA-and NF-kappaB-independent mechanisms. Cell Signal 2007;19:251-260
41. Eijkelkamp N, Cobelens PM, Sanders VM, et al: Tissue specific effects of the beta 2-adrenergic agonist salbutamol on LPS-induced IFN-gamma, IL-10 and TGF-beta responses in vivo. J Neuroimmunol 2004;150:3-9
42. Barrett LK, Singer M, Clapp LH: Vasopressin: Mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 2007;35:33-40
43. Kondo A, Mogi M, Koshihara Y, et al: Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells. Biochem Pharmacol 2001;61:319-326
44. Abdel-Razzak Z, Loyer P, Fautrel A, et al: Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 1993;44:707-715
45. Rodriguez-Antona C, Bort R, Jover R, et al: Transcriptional regulation of human CYP3A4 basal expression by CCAAT enhancer-binding protein alpha and hepatocyte nuclear factor-3 gamma. Mol Pharmacol 2003;63:1180-1189
46. Guillouzo A: Liver cell models in in vitro toxicology. Environ Health Perspect 1998;106(Suppl 2):511-532
47. Monshouwer M, Hoebe KH: Hepatic (dys-) function during inflammation. Toxicol In Vitro 2003;17:681-686
48. Zhou M, Yang S, Koo DJ, et al: The role of Kupffer cell alpha (2)-adrenoceptors in norepinephrine-induced TNF-alpha production. Biochim Biophys Acta 2001;1537:49-57
49. Ebert EC: Hypoxic liver injury. Mayo Clin Proc 2006;81:1232-1236
50. Szabo G, Romics L Jr, Frendl G: Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis 2002;6:1045-1066
51. Praaning-van Dalen DP, Brouwer A, Knook DL: Clearance capacity of rat liver Kupffer, endothelial, and parenchymal cells. Gastroenterology 1981;81:1036-1044 (Pubitemid 11029682)
52. Yasui M, Nakao A, Yuuki T, et al: Immunohistochemical detection of endotoxin in endotoxemic rats. Hepatogastroenterology 1995;42:683-690
53. van Oosten M, van de Bilt E, van Berkel TJ, et al: New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells. Infect Immun 1998;66:5107-5112
54. Renton KW: Alteration of drug biotransformation and elimination during infection and inflammation. Pharmacol Ther 2001;92:147-163
55. Hall GM, Peerbhoy D, Shenkin A, et al: Hip and knee arthroplasty: A comparison and the endocrine, metabolic and inflammatory responses. Clin Sci (Lond) 2000;98:71-79
56. Harbrecht BG, Frye RF, Zenati MS, et al: Cytochrome P-450 activity is differentially altered in severely injured patients. Crit Care Med 2005;33:541-546
57. Crawford JH, Yang S, Zhou M, et al: Downregulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsis. Crit Care Med 2004;32:502-508
58. Haas CE, Kaufman DC, Jones CE, et al: Cytochrome P450 3A4 activity after surgical stress. Crit Care Med 2003;31:1338-1346
59. Lauzier F, Levy B, Lamarre P, et al: Vasopressin or norepinephrine in early hyperdynamic septic shock: A randomized clinical trial. Intensive Care Med 2006;32:1782-1789
60. Rendic S, Di Carlo FJ: Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev 1997;29:413-580